These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7226704)

  • 1. Kinetics and bioavailability of mexiletine in healthy subjects.
    Häselbarth V; Doevendans JE; Wolf M
    Clin Pharmacol Ther; 1981 Jun; 29(6):729-36. PubMed ID: 7226704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dissolution and oral bioavailability of mexiletine capsules modified for clinical trial. A preliminary report.
    Chan K; Tse J; Deeks PA; Pilling M
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):471-8. PubMed ID: 6668966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenous mexiletine in patients with acute myocardial infarction.
    Pentikäinen PJ; Halinen MO; Helin MJ
    J Cardiovasc Pharmacol; 1984; 6(1):1-6. PubMed ID: 6199590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of mexiletine in renal insufficiency.
    Baudinet G; Henrard L; Quinaux N; El Allaf D; de Landsheere C; Carlier J; Dresse A
    Acta Cardiol Suppl; 1980; (25):55-65. PubMed ID: 6966453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective disposition of mexiletine in man.
    Grech-Belanger O; Turgeon J; Gilbert M
    Br J Clin Pharmacol; 1986 May; 21(5):481-7. PubMed ID: 3718807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of oral mexiletine in patients with acute myocardial infarction.
    Pentikäinen PJ; Halinen MO; Helin MJ
    Eur J Clin Pharmacol; 1983; 25(6):773-7. PubMed ID: 6662176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mexiletine kinetics in healthy subjects taking cimetidine.
    Klein A; Sami M; Selinger K
    Clin Pharmacol Ther; 1985 Jun; 37(6):669-73. PubMed ID: 4006366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rifampicin treatment on the kinetics of mexiletine.
    Pentikäinen PJ; Koivula IH; Hiltunen HA
    Eur J Clin Pharmacol; 1982; 23(3):261-6. PubMed ID: 6129140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced metabolism of mexiletine after phenytoin administration.
    Begg EJ; Chinwah PM; Webb C; Day RO; Wade DN
    Br J Clin Pharmacol; 1982 Aug; 14(2):219-23. PubMed ID: 7104173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution and elimination of mexiletine.
    Prescott LF; Pottage A; Clements JA
    Postgrad Med J; 1977; 53 Suppl 1():50-5. PubMed ID: 876954
    [No Abstract]   [Full Text] [Related]  

  • 11. Cirrhosis of the liver markedly impairs the elimination of mexiletine.
    Pentikäinen PJ; Hietakorpi S; Halinen MO; Lampinen LM
    Eur J Clin Pharmacol; 1986; 30(1):83-8. PubMed ID: 3709636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias.
    Ohashi K; Ebihara A; Hashimoto T; Hosoda S; Kondo K; Oka T
    Arzneimittelforschung; 1984; 34(4):503-7. PubMed ID: 6540110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of metoclopramide and atropine on the absorption of orally administered mexiletine.
    Wing LM; Meffin PJ; Grygiel JJ; Smith KJ; Birkett DJ
    Br J Clin Pharmacol; 1980 May; 9(5):505-9. PubMed ID: 6994791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cigarette smoking on mexiletine kinetics.
    Grech-Bélanger O; Gilbert M; Turgeon J; LeBlanc PP
    Clin Pharmacol Ther; 1985 Jun; 37(6):638-43. PubMed ID: 4006363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of mexiletine in renal insufficiency.
    El Allaf D; Henrard L; Crochelet L; Delapierre D; Carlier J; Dresse A
    Br J Clin Pharmacol; 1982 Sep; 14(3):431-5. PubMed ID: 7126416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine disposition: individual variation in response to urine acidification and alkalinisation.
    Mitchell BG; Clements JA; Pottage A; Prescott LF
    Br J Clin Pharmacol; 1983 Sep; 16(3):281-4. PubMed ID: 6626420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and nondialyzability of mexiletine in renal failure.
    Wang T; Wuellner D; Woosley RL; Stone WJ
    Clin Pharmacol Ther; 1985 Jun; 37(6):649-53. PubMed ID: 4006364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of spontaneous changes in urinary pH on mexiletine plasma concentrations and excretion during chronic administration to healthy volunteers.
    Johnston A; Burgess CD; Warrington SJ; Wadsworth J; Hamer NA
    Br J Clin Pharmacol; 1979 Oct; 8(4):349-52. PubMed ID: 41549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption and antiarrhythmic efficacy of sustained-release mexiletine.
    Holt DW; Chadwick DE; Campbell RW
    Clin Ther; 1983; 5(3):268-78. PubMed ID: 6850720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.